The Surging Popularity of GLP-1s By 2024, approximately 4% of Americans were taking a GLP-1 receptor agonist for weight loss, obesity, or type 2 diabetesa staggering 600% increase since 2018
Researchers tested whether restoring MOTS-c could reverse these declines
While studies suggest promising effects of allulose, it's important to approach these findings with caution , given that many were conducted by researchers with disclosed conflicts of interest, which may bias study design, analysis, or reporting
Brello Health GLP-1 Medication Options FAQ Spotlight: Is a specific medication or brand guaranteed on Brello Health
Feel the Difference with Hydralive Therapy Both vitamin B12 and lipotropic injections have the potential to improve your health, well-being, and quality of life